© 1993 Oxford University Press
research-article |
Depression of catalase gene expression after immortalization and transformation of mouse liver cells
Cell Biology Section, Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center Frederick, MD
1Radiation Research Laboratory, 14 Medical Laboratories, The University of lowa IA, USA
To understand the molecular basis of the remarkable decrease of catalase activity after immortalization and malignant transformation of mouse liver cells, expression of the catalase gene was studied in in vivo mouse liver cells and nontrans-formed normal mouse liver cell line as well as liver cell lines transformed by N-methyl-N-nitro-N-nitrosoguanidine, SV40 virus or by conventional subcultivation. In vivo liver cells had much greater levels of catalase mRNA and immunoreactive protein than in vitro cell lines, which correlates with elevated enzyme activity. Among the cell lines, normal cells had in general higher mRNA levels and more catalase protein than that of the transformed cell lines, also correlating with enzyme activity. The down regulation of catalase gene expression seen in transformed lines may occur transcriptionally rather than posttranscriptionally as demonstrated by cycloheximide and/or actinomycin D treatment. The striking difference in catalase gene expression seen between liver tissue and liver cell lines was unlikely due to gross structural alterations in the catalase gene, but might be explained by a remarkable difference in methylation status of the catalase gene, as demonstrated by Southern blot analysis following HpaII digestion. Our results suggested that during cellular immortalization and malignant transformation, a change in the oxidant stress ultimately led to a cellular response that, in turn, led to down regulation of the catalase gene.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Li and H. E. Schellhorn New Developments and Novel Therapeutic Perspectives for Vitamin C J. Nutr., October 1, 2007; 137(10): 2171 - 2184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Gonzalez, J. R. Miranda-Massari, E. M. Mora, A. Guzman, N. H. Riordan, H. D. Riordan, J. J. Casciari, J. A. Jackson, and A. Roman-Franco Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later Integr Cancer Ther, March 1, 2005; 4(1): 32 - 44. [Abstract] [PDF]
|
|
|
|
 |
|
 G. D. Girnun, F. E. Domann, S. A. Moore, and M. E. C. Robbins Identification of a Functional Peroxisome Proliferator-Activated Receptor Response Element in the Rat Catalase Promoter Mol. Endocrinol., December 1, 2002; 16(12): 2793 - 2801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Brown, F. J. Miller Jr, W.-G. Li, A. N. Ellingson, J. D. Mozena, P. Chatterjee, J. F. Engelhardt, R. M. Zwacka, L. W. Oberley, X. Fang, et al. Overexpression of Human Catalase Inhibits Proliferation and Promotes Apoptosis in Vascular Smooth Muscle Cells Circ. Res., September 17, 1999; 85(6): 524 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lauer, A. Volkl, S. Riedl, H. D. Fahimi, and K. Beier Impairment of peroxisomal biogenesis in human colon carcinoma Carcinogenesis, June 1, 1999; 20(6): 985 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sun, G. Hegamyer, H. Kim, K. Sithanandam, H. Li, R. Watts, and N. H. Colburn Molecular Cloning of Mouse Tissue Inhibitor of Metalloproteinases-3 and Its Promoter J. Biol. Chem., August 18, 1995; 270(33): 19312 - 19319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dayal, T. Bottiglieri, E. Arning, N. Maeda, M. R. Malinow, C. D. Sigmund, D. D. Heistad, F. M. Faraci, and S. R. Lentz Endothelial Dysfunction and Elevation of S-Adenosylhomocysteine in Cystathionine {beta}-Synthase-Deficient Mice Circ. Res., June 8, 2001; 88(11): 1203 - 1209. [Abstract] [Full Text] [PDF]
|
|